My watch list
my.bionity.com  
Login  
MARKET STUDIES
News on market trends
  • New lung 'organoids' in a dish mimic features of full-size lung

    New lung "organoids"--tiny 3-D structures that mimic features of a full-sized lung--have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC). The team used the organoids to generate models of human lung diseases in a lab dish, which could be use more

  • DKSH extends partnership with LAUDA to Singapore and Taiwan

    DKSH, the leading Market Expansion Services provider with a focus on Asia, and LAUDA, a global leader in manufacturing thermal-controlling instruments, have signed a distributor agreement for Singapore and Taiwan for the product line of constant temperature equipment. DKSH Business Unit Technology a more

  • Signaling Continued Investment in China, Bruker Open Beijing Center of Excellence

    Bruker celebrated the opening of the Beijing Center of Excellence, an expansive and modern demo facility that will support China’s scientific research community. The opening of the Center represents a new milestone in Bruker’s long history in China, which began in 1975 with the sale of two FT-only N more

  • Analytik Jena enters Ultra-High Throughput Market

    Analytik Jena has entered a partnership with Illumina, Inc. headquartered in San Diego. In so doing Analytik Jena gains access to the growing genotyping market currently being served by Illumina’s technologies by offering a production scale solution to provide ultra-high throughput sample preparatio more

  • Recipharm completes strategic acquisition in India

    Recipharm AB announces that it has now concluded the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India. The expands position in emerging markets significantly, taking sales in these markets to more than SEK 800 million, dominated by sales directly to the fast-growing pha more

  • Merck opens production facility exclusively for meglumine in Spain

    Merck announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.The facility, validated by the FDA, is the only location in Europe that manufactures meglum more

  • Grünenthal introduces Latin America’s most modern Women’s Health Products plant

    Grünenthal announced the introduction of its new women’s health products plant today. Grünenthal invested USD 14.5 million to build the 1,150 m 2 hormone plant, which is the company’s center of excellence for hormone production and the most modern in Latin America. The new facility will initially de more

  • WACKER expands its production of cysteine

    WACKER BIOSOLUTIONS, the life sciences and biotechnology division of the WACKER Group, is acquiring a large-scale fermentation plant from Antibióticos de León SLU (ADL) in Spain. The two companies announced the signing of the contract of sale. At the León plant, WACKER will produce cysteine by ferme more

  • Takeda to invest more than 100 million Euros in dengue vaccine manufacturing plant

    Takeda Pharmaceutical Company Limited announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany. This represents a major step by Takeda toward meeting important unmet needs in dengue prevention. According to the W more

  • Novozymes expands in India

    To accommodate business growth and a consequent increase in production and supply chain needs, Novozymes has obtained land on a long-term lease in the Patalganga industrial area near Mumbai on India’s west coast. With an initial investment of approximately DKK 300 million the company plans to establ more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE